Terms: = Testicular cancer AND LDH AND Diagnosis
69 results:
1. [Extragonadal germ cell tumor: A case report and review of the literature].
Li P; Wu D; Xu XF; Fu D; Jia RP; Ge JP
Zhonghua Nan Ke Xue; 2022 Nov; 28(11):1026-1030. PubMed ID: 37846120
[TBL] [Abstract] [Full Text] [Related]
2. Absolute monocyte count has a diagnostic role in distinguishing tumor marker-negative TGCT from benign testicular tumor via CCL2 regulation.
Cao L; Chang Q; Sun J; Pang S; Fan Y; Liu J
Medicine (Baltimore); 2023 Jun; 102(25):e34114. PubMed ID: 37352031
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of the M371-Test Under Real-life Conditions for diagnosis and Follow Up of testicular Germ Cell Tumors.
Pycha S; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; Trenti E
Anticancer Res; 2023 Apr; 43(4):1649-1653. PubMed ID: 36974797
[TBL] [Abstract] [Full Text] [Related]
4. Εmerging Biomarkers in the diagnosis and Treatment of testicular Tumors.
Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
[TBL] [Abstract] [Full Text] [Related]
5. French AFU cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
[TBL] [Abstract] [Full Text] [Related]
6. [Biomarkers in testicular cancer.].
Mayor-de-Castro J; Aragón-Chamizo J; Caño-Velasco J; Hernández-Fernández C
Arch Esp Urol; 2022 Mar; 75(2):113-117. PubMed ID: 35332880
[TBL] [Abstract] [Full Text] [Related]
7. Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor.
Barragán-Carrillo R; Mateos-Corella S; Ortiz-Hidalgo C; Izquierdo-Echavarri E; Castillejos-Molina R; Angel M; Barragan-Arteaga I; Flaig T; Bourlon MT
Oncology (Williston Park); 2021 Dec; 35(12):816-819. PubMed ID: 35088997
[TBL] [Abstract] [Full Text] [Related]
8. Predictors of Venous Thromboembolism in Patients With testicular Germ Cell Tumors: A Retrospective Study.
Abdel-Razeq H; Tamimi F; Abdel-Razeq R; Salah S; Omari Z; Salama O; Abufara A; Al-Tell A; Qahoush H; Nasman A; Taqash A; Alhalaseh Y; Bater R
Clin Appl Thromb Hemost; 2021; 27():10760296211024756. PubMed ID: 34121471
[TBL] [Abstract] [Full Text] [Related]
9. Serum tumour markers in germ cell tumours: From diagnosis to cure.
Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
[TBL] [Abstract] [Full Text] [Related]
10. [French ccAFU guidelines - update 2020-2022: testicular germ cell tumors].
Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
Prog Urol; 2020 Nov; 30(12S):S280-S313. PubMed ID: 33349427
[TBL] [Abstract] [Full Text] [Related]
11. Does Determining Tumor Markers from the testicular Vein Enable Better diagnosis and Prognosis?
Zauner T; Heidler S; Lusuardi L; Albrecht W; Wimpissinger F
Urol Int; 2021; 105(3-4):264-268. PubMed ID: 33333530
[TBL] [Abstract] [Full Text] [Related]
12. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
[TBL] [Abstract] [Full Text] [Related]
13. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic testicular Germ Cell cancers Before, During and After Chemotherapy.
Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ
Cells; 2019 Oct; 8(10):. PubMed ID: 31597402
[TBL] [Abstract] [Full Text] [Related]
14. [Metachronous Development of Mantle Cell Lymphoma during Active Surveillance in a Patient with Stage I testicular cancer].
Sano K; Kimura T; Kawai K; Ikeda A; Ishitsuka R; Kandori S; Waku N; Hoshi A; Kojima T; Joraku A; Hashimoto R; Nishiyama H
Hinyokika Kiyo; 2018 Dec; 64(12):509-513. PubMed ID: 30831668
[TBL] [Abstract] [Full Text] [Related]
15. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
[TBL] [Abstract] [Full Text] [Related]
16. MiR-371a-3p Serum Levels Are Increased in Recurrence of testicular Germ Cell Tumor Patients.
Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
[TBL] [Abstract] [Full Text] [Related]
17. Peritoneal Myeloid Sarcoma in a Patient Treated for a testicular Seminoma.
Longo R; Dorvaux V; Chatelain E; Quétin P; Plastino F; Eid N; Marcon N; Hennequin L; Campitiello M
Am J Case Rep; 2018 Jun; 19():763-766. PubMed ID: 29955031
[TBL] [Abstract] [Full Text] [Related]
18. Germ cell tumor causing pleural effusion: A diagnostic dilemma.
Jaggi S; Kundu R; Binji S; Handa U; Saini V
Indian J Tuberc; 2018 Jan; 65(1):80-83. PubMed ID: 29332656
[TBL] [Abstract] [Full Text] [Related]
19. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
van Agthoven T; Eijkenboom WMH; Looijenga LHJ
Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
[TBL] [Abstract] [Full Text] [Related]
20. Primary retroperitoneal seminoma - embryology, histopathology and treatment particularities.
Gîngu CV; Mihai M; Baston C; Crăsneanu MA; Dick AV; Olaru V; Sinescu I
Rom J Morphol Embryol; 2016; 57(3):1045-1050. PubMed ID: 28002522
[TBL] [Abstract] [Full Text] [Related]
[Next]
